However, using compounded products as a replacement can be risky
doi: 10.3389/fmolb.2025.1724944 Received 14 October 2025 Revised 18 November 2025 Accepted 30 November 2025 Published 18 December 2025 Volume 12 - 2025 Edited by Maria Barile, University of Bari Aldo Moro, Italy Reviewed by Anna Maria Giudetti, University of Salento, Italy Maria Tolomeo, National Research Council (CNR), Italy Updates Copyright 2025 Schrder, Jalilvand, Kahl, Kaiser and Liebau
According to the press release, the green list will permit entry to GLP-1 APIs sourced from facilities the FDA has inspected or evaluated and deemed compliant with agency standards
The per member per month (PMPM) cost has increased exponentially, forcing many to implement cost controls
We use pharmaceutical-grade peptides only